Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Laser hair removal is safe and effective for fair-skinned people with dark hair, and using eflornithine with laser treatments can improve results.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Blocking testosterone speeds up wound healing in males.

Male hormones can decrease the ability of immune cells to fight bacteria.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride and finasteride affect different cell types differently.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Blocking testosterone speeds up wound healing in males.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Minoxidil can reduce functions related to androgen receptors.

Androgen use may increase the risk of stroke, but more research is needed.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Finasteride in male rats causes liver and metabolic issues in their offspring.